Cargando…

Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study

SIMPLE SUMMARY: Multiple myeloma (MM) is characterized by an expansion of plasma cells in the bone marrow (BM). The genetics of MM are highly complex with multiple mutations and genetic subpopulations of tumor cells that arise during the disease evolution, affecting prognosis and treatment response....

Descripción completa

Detalles Bibliográficos
Autores principales:	Heestermans, Robbe, De Brouwer, Wouter, Maes, Ken, Vande Broek, Isabelle, Vaeyens, Freya, Olsen, Catharina, Caljon, Ben, De Becker, Ann, Bakkus, Marleen, Schots, Rik, Van Riet, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563447/ https://www.ncbi.nlm.nih.gov/pubmed/36230824 http://dx.doi.org/10.3390/cancers14194901

Ejemplares similares

Genetic profiling of human bone marrow mesenchymal stromal cells after in vitro expansion in clinical grade human platelet lysate
por: De Becker, Ann, et al.
Publicado: (2022)

The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma
por: Faict, Sylvia, et al.
Publicado: (2019)

Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma
por: Fostier, Karel, et al.
Publicado: (2012)

Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma
por: Wang, Jinheng, et al.
Publicado: (2016)

Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients
por: Xu, Song, et al.
Publicado: (2013)

A case report of immunosuppression-related Kaposi’s sarcoma after autologous stem cell transplantation
por: Heyrman, Bert, et al.
Publicado: (2016)

Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still’s disease: when dosage matters in overcoming secondary therapy resistance
por: Ajeganova, Sofia, et al.
Publicado: (2020)

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
por: Faict, Sylvia, et al.
Publicado: (2018)

Laminin-1-induced migration of multiple myeloma cells involves the high-affinity 67 kD laminin receptor
por: Vande Broek, I, et al.
Publicado: (2001)

Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3
por: Broek, I Vande, et al.
Publicado: (2003)

Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse
por: Vanderkerken, K, et al.
Publicado: (2000)

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation
por: Fostier, Karel, et al.
Publicado: (2018)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic
por: Bieghs, Liesbeth, et al.
Publicado: (2014)

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2013)

Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
por: Xu, Song, et al.
Publicado: (2018)

A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma
por: Rajeev Krishnan, Sabna, et al.
Publicado: (2020)

Liquid biopsies for multiple myeloma in a time of precision medicine
por: Ferreira, Bruna, et al.
Publicado: (2020)

Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model
por: Nur, Haneen, et al.
Publicado: (2013)

Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
por: Muylaert, Catharina, et al.
Publicado: (2022)

Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
por: Oudaert, Inge, et al.
Publicado: (2022)

Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma
por: GOZZETTI, ALESSANDRO, et al.
Publicado: (2023)

Specific roles for the PI3K and the MEK–ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model
por: Menu, E, et al.
Publicado: (2004)

The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations.
por: Radl, J., et al.
Publicado: (1990)

The therapeutic potential of cell cycle targeting in multiple myeloma
por: Maes, Anke, et al.
Publicado: (2017)

ATTR Cardiomyopathy Meets Multiple Myeloma: The Importance of Cardiac Biopsy
por: Kanelidis, Anthony J., et al.
Publicado: (2021)

Metabolic Features of Multiple Myeloma
por: El Arfani, Chaima, et al.
Publicado: (2018)

Transcriptomic differences between fibrotic and non-fibrotic testicular tissue reveal possible key players in Klinefelter syndrome-related testicular fibrosis
por: Willems, Margo, et al.
Publicado: (2022)

Peripheral precocious puberty in Li–Fraumeni syndrome: a case report and literature review of pure androgen-secreting adrenocortical tumors
por: Ryckx, Sofie, et al.
Publicado: (2023)

Optimization and Characterization of a Galleria mellonella Larval Infection Model for Virulence Studies and the Evaluation of Therapeutics Against Streptococcus pneumoniae
por: Cools, Freya, et al.
Publicado: (2019)

Development of Novel Isoindolone‐Based Compounds against Trypanosoma brucei rhodesiense
por: Silva, Daniel G., et al.
Publicado: (2021)

Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma
por: Li, Shuchan, et al.
Publicado: (2023)

Rare case of plasmablastic myeloma diagnosed on lung biopsy
por: Ayeboa-Sallah, Benjamin, et al.
Publicado: (2021)

The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs
por: van der Poort, Esmée K. J., et al.
Publicado: (2022)

Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma
por: Setayesh, Sonia M., et al.
Publicado: (2023)

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022)

Circulation of HRSV in Belgium: From Multiple Genotype Circulation to Prolonged Circulation of Predominant Genotypes
por: Houspie, Lieselot, et al.
Publicado: (2013)

Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
por: van der Laan, Pia, et al.
Publicado: (2021)

Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment
por: Leleu, X, et al.
Publicado: (2017)

Investigating Predictors of Visiting, Using, and Revisiting an Online Health-Communication Program: A Longitudinal Study
por: Van 't Riet, Jonathan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_v1u92ni1bicc3qg6knds1jror6